{"id":"W3176887745","doi":"10.3390/jcm10132914","title":"Effectiveness of Third-Class Biologic Treatment in Crohn’s Disease: A Multi-Center Retrospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal General Hospital","funders":"Cilag; Dr. Falk Pharma; Shire; Tillotts Pharma; Novo Nordisk; Samsung; Celgene; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Vedolizumab; Internal medicine; Retrospective cohort study; Crohn's disease; Ustekinumab; Cohort; Surgery; Gastroenterology; Disease; Infliximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002638367,0.0003396013,0.000731555,0.0007633716,0.0005914479,0.0008674936,0.0005068458,0.0006078268,0.001084247],"category_scores_gemma":[0.003887389,0.0003745097,0.001111507,0.001076572,0.0003859125,0.0007134333,0.0005654902,0.0007380975,0.0002257575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005043003,"about_ca_system_score_gemma":0.0004505477,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001407755,"about_ca_topic_score_gemma":0.001560888,"domain_scores_codex":[0.9979663,0.0006914648,0.0003192989,0.0004696307,0.0003391136,0.0002143289],"domain_scores_gemma":[0.993714,0.000920719,0.003711809,0.0007694158,0.0003374738,0.0005464921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004852509,0.00004938441,0.998475,0.00001157144,0.000127035,0.00006760615,0.00004245748,0.00001809922,0.0001132297,0.000007501792,0.00003988325,0.0005629623],"study_design_scores_gemma":[0.00006667405,0.0008138319,0.9974279,0.00001547373,0.0001638722,0.0007629688,0.0002093598,0.0001750391,0.00009749441,0.00001476133,0.000242847,0.00000974937],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992197,0.0003543201,0.00005918148,0.00001824357,0.000005637544,0.00001541568,0.0002077835,0.000001486952,0.0001183322],"genre_scores_gemma":[0.9993237,0.0001441247,0.00009719531,0.00002614143,0.00001218918,0.00002047894,0.0003349756,0.000002157328,0.00003901736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002638367,"threshold_uncertainty_score":0.01395321,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03038268239310553,"score_gpt":0.3841626042459117,"score_spread":0.3537799218528062,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}